Lung cancer
Conditions
Interventions
Intervention group:Lung cancer patients in the intervention group filled out the PRO scale every week, and the scale scores were used to provide feedback on symptom management suggestions for patients
Control group:Usual Care
Sponsors
China Center for Health Development Studies, Peking University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1) Adults aged 18 years and above; 2) Lung cancer patients with locally advanced or metastatic disease during or after chemotherapy or immunotherapy; 3) Patients or their caregivers own a smartphone and can use WeChat public accounts, receive calls and text messages; 4) Informed consent.
Exclusion criteria
Exclusion criteria: 1) Having cognitive impairment, or being unable to clearly recognize their own symptoms and feelings; 2) Being illiterate or unable to understand the research content for other reasons; 3) Currently participating in other clinical trials that may affect this study; 4) Suffering from other malignant tumors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Health-related quality of life;Adverse Symptom;Study Satisfaction; | — |
Secondary
| Measure | Time frame |
|---|---|
| Survival;Phisical function;Symptom control;Health utility;Mental health;Self management;Study burden;Study compliance;Oupatient, inpatient and emergency department visits;Direct medical costs;Direct non-medical costs;Porductivity lost; | — |
Countries
China
Contacts
Public ContactPing He
China Center for Health Development Studies, Peking University
Outcome results
None listed